Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

34.19
-0.4100-1.18%
Post-market: 33.91-0.2800-0.82%19:58 EDT
Volume:1.26M
Turnover:42.67M
Market Cap:2.45B
PE:-5.80
High:34.47
Open:34.40
Low:33.34
Close:34.60
52wk High:56.05
52wk Low:21.20
Shares:71.71M
Float Shares:62.80M
Volume Ratio:0.55
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:6.01
PE(LYR):-7.33

Loading ...

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), Vera Therapeutics (VERA) and Regeneron (REGN)

TIPRANKS
·
Jun 02

Vera Therapeutics Advances Atacicept Approval Path in IgA Nephropathy

TIPRANKS
·
Jun 02

BUZZ-Vera rises as FDA agrees to review late-stage kidney drug data for full approval

Reuters
·
Jun 02

Vera Therapeutics pulls forward ORIGIN phase 3 eGFR analysis of atacicept in IgA nephropathy to Q3 2026

Reuters
·
Jun 02

Vera Therapeutics, - Revised Origin 3 Egfr Analysis Planned for Q3 2026

THOMSON REUTERS
·
Jun 02

Vera Therapeutics Announces Alignment With U.S. FDA on Earlier Origin Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults With Iga Nephropathy

THOMSON REUTERS
·
Jun 02

Vera Therapeutics, - Pdufa Date Set for July 7, 2026 for Atacicept in Igan

THOMSON REUTERS
·
Jun 02

Vera Therapeutics, - Plans to Submit Sbla in Q4 2026 for Potential Full Approval in 2027

THOMSON REUTERS
·
Jun 02

Vera Therapeutics shareholders elect Class II directors at annual meeting

Reuters
·
May 27

Analysts’ Top Healthcare Picks: Concentra Group Holdings Parent, Inc. (CON), Vera Therapeutics (VERA)

TIPRANKS
·
May 23

Analysts Are Bullish on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Vera Therapeutics (VERA)

TIPRANKS
·
May 22

Vera Therapeutics (VERA) Is Down 11.6% After Wider Q1 Loss Highlights Rising Cost Burden

Simply Wall St.
·
May 22

Vera Therapeutics Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 16

Vera Therapeutics (VERA) Receives a Buy from Evercore ISI

TIPRANKS
·
May 15

Vera Therapeutics CEO Marshall Fordyce disposes 18,500 shares for $834,058

Reuters
·
May 14

Vera Therapeutics grants inducement equity awards to 10 new hires, sets options at $35.51

Reuters
·
May 09

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained

TIPRANKS
·
May 08

Kodiak Begins Hauling Freight Autonomously With Roehl Transport

GlobeNewswire
·
May 08

Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37)

TIPRANKS
·
May 08